MIB-1 Labelling Index as a Prognostic Marker in Breast Cancer
Author Information
Author(s): RLH Jansen, PSGJ Hupperets, JW Arends, SR Joosten-Achjanie, A Volovics, HC Schouten, HFP Hillen
Primary Institution: University Hospital Maastricht
Hypothesis
The MIB-1 labelling index is a significant prognostic factor in primary breast cancer.
Conclusion
The MIB-1 labelling index is an important prognostic factor for disease-free survival in patients with primary breast cancer.
Supporting Evidence
- MIB-1 had prognostic value for disease-free survival in the whole group of patients.
- MIB-1 was an independent prognostic factor besides axillary lymph node status.
- High S-phase fraction was associated with decreased overall survival in univariate analysis.
Takeaway
This study found that a specific marker called MIB-1 can help doctors predict how well patients with breast cancer will do after treatment.
Methodology
The study analyzed the MIB-1 labelling index in 341 patients with primary breast cancer and compared it with the S-phase fraction in 220 patients.
Limitations
The follow-up period was relatively long, but the study may not have included enough diverse patient demographics.
Participant Demographics
Median age was 57 years, with a range from 25 to 87 years; 64.5% underwent modified radical mastectomy.
Statistical Information
P-Value
0.004
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website